Anish Bhatnagar (CIK 1614821) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-18). Recent activity: Sell SLNO (583,656 shares), Buy SLNO (114,200 shares), Sell SLNO (7,620 shares), Sell SLNO (100,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-18 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 583,656 | $0 |
| 2026-01-23 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Buy | 114,200 | $0 |
| 2025-12-17 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 7,620 | $380,619 |
| 2025-12-17 | SOLENO THERAPEUTICS INC (SLNO) | CHIEF EXECUTIVE OFFICER | Sell | 100,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-05-18